Mizuho Securities analyst Vijay Rakesh reiterated a Hold rating on Texas Instruments (TXN – Research Report) today and set a price target of ...

Merck released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA ...

Mizuho, BofA Securities, MUFG and Truist Securities are serving as joint book-running managers for the underwritten public offering.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The issuances include an inaugural $2.4 billion CMBS offering and a $1.1 billion ABS offering The CMBS issuance of $2.4 billion is the largest green data center CMBS transaction ever completed ...

Schizophrenia affects millions worldwide, yet its causes remain one of the greatest medical mysteries. In an exclusive Genomic Press Interview, Dr. Consuelo Walss-Bass, a pioneering researcher in ...

Experts discuss how cancer treatment and survivorship can be made more equitable and affordable through advocacy, outreach, and effective communication tools. Beyond Cancer: Caring for Young ...

Schizophrenia affects millions worldwide, yet its causes remain one of the greatest medical mysteries. In an exclusive Genomic Press Interview, Dr. Consuelo Walss-Bass, a pioneering researcher in ...

Business.com earns commissions from some listed providers. Editorial Guidelines. Medical software is a required part of modern medical practices, not only for regulatory compliance but also for ...